Marktanalyse - Buyer Spend Activity and Procurement Behaviors and Strategies in the Pharmaceutical Industry - 2012-2013 : Survey Intelligence
ICD Research
6 / 2012
73 Seiten
| Typ: | Marktanalyse |
| Sprache: | Englisch |
| Regionen: | Europa, Asien / Pazifik, Mittlerer Osten / Afrika, Nordamerika / USA, Australien, Mittel- / Südamerika |
| Verfügbarkeit: | verfügbar |
Bitte wählen Sie ein Lieferformat und klicken Sie unten auf einen Bestellbutton:
Marktanalyse - Buyer Spend Activity and Procurement Behaviors and Strategies in the Pharmaceutical Industry - 2012-2013 : Survey Intelligence
Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives.
• Analysis on how procurement expenditure, business strategies and practices in the pharmaceutical industry are set to change in 2011-2012.
• Analysis on spending plans, budget allocations, challenges and investment opportunities of purchase decision makers.
Summary
This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives. It analyzes how procurement expenditure, business strategies and practices are set to change in the pharmaceutical industry in 2012-13. This report gives you access to the category-level spending outlooks, budgets, supplier selection criteria, business challenges and investment opportunities for leading purchase decision makers. The report also identifies future growth of buyers and suppliers and e-procurement. This report not only grants access to the opinions and strategies of business decision makers and competitors, but also examines their actions surrounding business priorities. The report also provides access to information categorized by region, company type and size.
Scope
• The opinions and forward looking statements of 247 industry executives have been captured in our in-depth survey, of which 51% represent Director and C-level respondents.
• The research is based on primary survey research conducted by ICD Research accessing its B2B panels comprised of senior purchase decision makers and leading supplier organizations.
• The geographical scope of the research is global - drawing on the activity and expectations of leading industry players across the Americas, Europe, Asia-Pacific, Africa and Middle East.
• Key topics covered include buyer expenditure activity, procurement behaviors and strategies, threats and opportunities, economic outlook and business confidence.
• In the report, buyers identify what suppliers need to do to maintain their business and the key actions being taken by industry players to overcome the leading business threats.
• The report examines current practices and provides future expectations for the industry over the next 12-24 months.
Reasons To Buy
• This report will help you to drive revenues by understanding future product investment areas and growth regions.
• This report will help you to formulate effective sales and marketing strategies by identifying how buyer budgets are changing and the direction of spend in the future.
• This report will help you to better promote your business by aligning your capabilities and business practices with your customer’s changing needs.
• This report will help you to secure stronger customer relationships by understanding the leading business concerns and changing strategies of industry buyers.
• This report will help you to predict how the industry will grow, consolidate and where it will stagnate.
• This report will help you to uncover the business outlook, key challenges and opportunities identified by suppliers and buyers.
Companies Mentioned:
NA
Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives.
• Analysis on how procurement expenditure, business strategies and practices in the pharmaceutical industry are set to change in 2011-2012.
• Analysis on spending plans, budget allocations, challenges and investment opportunities of purchase decision makers.
Summary
This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives. It analyzes how procurement expenditure, business strategies and practices are set to change in the pharmaceutical industry in 2012-13. This report gives you access to the category-level spending outlooks, budgets, supplier selection criteria, business challenges and investment opportunities for leading purchase decision makers. The report also identifies future growth of buyers and suppliers and e-procurement. This report not only grants access to the opinions and strategies of business decision makers and competitors, but also examines their actions surrounding business priorities. The report also provides access to information categorized by region, company type and size.
Scope
• The opinions and forward looking statements of 247 industry executives have been captured in our in-depth survey, of which 51% represent Director and C-level respondents.
• The research is based on primary survey research conducted by ICD Research accessing its B2B panels comprised of senior purchase decision makers and leading supplier organizations.
• The geographical scope of the research is global - drawing on the activity and expectations of leading industry players across the Americas, Europe, Asia-Pacific, Africa and Middle East.
• Key topics covered include buyer expenditure activity, procurement behaviors and strategies, threats and opportunities, economic outlook and business confidence.
• In the report, buyers identify what suppliers need to do to maintain their business and the key actions being taken by industry players to overcome the leading business threats.
• The report examines current practices and provides future expectations for the industry over the next 12-24 months.
Reasons To Buy
• This report will help you to drive revenues by understanding future product investment areas and growth regions.
• This report will help you to formulate effective sales and marketing strategies by identifying how buyer budgets are changing and the direction of spend in the future.
• This report will help you to better promote your business by aligning your capabilities and business practices with your customer’s changing needs.
• This report will help you to secure stronger customer relationships by understanding the leading business concerns and changing strategies of industry buyers.
• This report will help you to predict how the industry will grow, consolidate and where it will stagnate.
• This report will help you to uncover the business outlook, key challenges and opportunities identified by suppliers and buyers.
Companies Mentioned:
NA
Inhaltsverzeichnis - Marktanalyse - Buyer Spend Activity and Procurement Behaviors and Strategies in the Pharmaceutical Industry - 2012-2013 : Survey Intelligence
1 Introduction
1.1 What is This Report About?
1.2 Definitions
1.3 Methodology
1.4 Profile of Survey Respondents: Global Pharmaceutical Industry
1.4.1 Profile of buyer respondents: global pharmaceutical industry
1.4.2 Profile of supplier respondents: global pharmaceutical industry
2 Executive Summary
3 Global Pharmaceutical Industry Buyer Spend Activity
3.1 Global Pharmaceutical Industry: Annual Procurement Budgets
3.1.1 Global pharmaceutical industry: annual procurement budgets by company type
3.1.2 Global pharmaceutical industry: annual procurement budgets by region
3.1.3 Global pharmaceutical industry: annual procurement budgets by company turnover
3.2 Global Pharmaceutical Industry: Planned Change in Procurement Spend
3.2.1 Global pharmaceutical industry: planned change in procurement spend by buyer type
3.2.2 Global pharmaceutical industry: planned change in procurement spend by region
3.2.3 Global pharmaceutical industry: planned change in procurement spend by company turnover
3.2.4 Global pharmaceutical industry: planned change in expenditure vs. revenue growth optimism
3.2.5 Global pharmaceutical industry: planned change in expenditure vs. cost containment
3.2.6 Global pharmaceutical industry: planned change in procurement spend - cross industry comparisons
3.3 Planned change in procurement spend by product and service category
3.3.1 Planned change in procurement spend by product and service category - region
3.3.2 Planned change in procurement spend by product and service category - company turnover
3.4 Global Pharmaceutical Industry: Variations in Regional Supplier Prices
3.4.1 Global pharmaceutical industry: variations in regional supplier prices by company type
3.4.2 Global pharmaceutical industry: variations in supplier prices by region
3.4.3 Global pharmaceutical industry: variations in regional supplier prices by company turnover
4 Global Pharmaceutical Industry:Procurement Behaviors and Strategies
4.1 Global Pharmaceutical Industry: Critical Success Factors for Supplier Selection
4.1.1 Global pharmaceutical industry: Critical success factors by company type
4.2 Future Procurement Objectives in the Global Pharmaceutical Industry
4.2.1 Future procurement objectives in the global pharmaceutical industry by company type
4.2.2 Future procurement objectives in the global pharmaceutical industry by region
4.2.3 Future procurement objectives in the global pharmaceutical industry by company turnover
4.3 E-procurement in the Global Pharmaceutical Industry
4.3.1 E-procurement in the global pharmaceutical industry by company type
4.3.2 E-procurement in the global pharmaceutical industry by region
4.3.3 E-procurement in the global pharmaceutical industry by company turnover
5 Appendix
5.1 Global Pharmaceutical Industry Survey Results - Closed Questions
5.2 Methodology
5.3 Contact us
5.4 About ICD Research
5.5 Disclaimer
Tabellenverzeichnis - Marktanalyse - Buyer Spend Activity and Procurement Behaviors and Strategies in the Pharmaceutical Industry - 2012-2013 : Survey Intelligence
Table 1: Total Global Pharmaceutical Industry Survey Respondents by Company Type, 2012
Table 2: Global Pharmaceutical Industry Buyer Respondents by Job Role (%), 2012
Table 3: Global Pharmaceutical Industry Buyer Respondents by Company Turnover (%), 2012
Table 4: Global Pharmaceutical Industry Buyer Respondents by Region (%), 2012
Table 5: Global Pharmaceutical Industry Supplier Respondents by Job Role (%), 2012
Table 6: Global Pharmaceutical Industry Supplier Respondents by Company Turnover (%), 2012
Table 7: Global Pharmaceutical Industry Supplier Respondents by Region (%), 2012
Table 8: Annual Procurement Budgets: Global Pharmaceutical Industry Buyers in US$ (%), 2010-2012
Table 9: Global Pharmaceutical Industry: Annual Procurement Budgets in US$ by Company (%), 2012
Table 10: Global Pharmaceutical Industry: Annual Procurement Budgets in US$ by Region (%), 2012
Table 11: Global Pharmaceutical Industry: Annual Procurement Budgets in US$ by Turnover (%), 2012
Table 12: Change in Total Procurement Expenditure of Global Pharmaceutical Industry Buyers (%), 2010-2012
Table 13: Global Pharmaceutical Industry: Change in Total Procurement Expenditure by Company Type (%), 2012
Table 14: Global Pharmaceutical Industry: Expected Change in Total Procurement Expenditure by Region (%), 2012
Table 15: Global Pharmaceutical Industry: Expected Change in Total Procurement Expenditure by Company Turnover (%), 2012
Table 16: Global Pharmaceutical Industry: Change in Expenditure vs. Revenue Growth (%), 2012
Table 17: Global Pharmaceutical Industry: Change in Expenditure vs. Cost Containment (%), 2012
Table 18: Planned Change in Procurement Spend: Cross Industry Comparison (%), 2012
Table 19: Global Pharmaceutical Industry Manufacturers: Change in Expenditure by Products and Services (%), 2012
Table 20: Global Pharmaceutical Industry CRO and CMO: Change in Expenditure by Products and Services (%), 2012
Table 21: Global Pharmaceutical Industry: Variations in Regional Supplier Prices (%), 2012
Table 22: Global Pharmaceutical Industry: Variations in Regional Supplier Prices by Company (%), 2012
Table 23: Global Pharmaceutical Industry: Variations in Supplier Prices by Region (%), 2012
Table 24: Global Pharmaceutical Industry: Variations in Regional Supplier Prices by Turnover (%), 2012
Table 25: Global Pharmaceutical Industry: Critical Success Factors for Supplier Selection - Buyers vs. Suppliers, 2012
Table 26: Critical Success Factors for Supplier Selection - All Global Pharmaceutical Industry Buyers, 2012
Table 27: Global Pharmaceutical Industry: Future Procurement Objectives (%), 2012
Table 28: Global Pharmaceutical Industry: Future Procurement Objectives by Company (%), 2012
Table 29: Global Pharmaceutical Industry: Future Procurement Objectives by Region (%), 2012
Table 30: Global Pharmaceutical Industry: Future Procurement Objectives by Turnover (%), 2012
Table 31: E-Procurement in the Global Pharmaceutical Industry(%), 2012
Table 32: E-Procurement in the Global Pharmaceutical Industry: by Company (%), 2012
Table 33: E-Procurement in the Global Pharmaceutical Industry by Region (%), 2012
Table 34: E-Procurement in the Global Pharmaceutical Industry by Turnover (%), 2012
Table 35: Survey Results - Closed Questions
Übersichtenverzeichnis - Marktanalyse - Buyer Spend Activity and Procurement Behaviors and Strategies in the Pharmaceutical Industry - 2012-2013 : Survey Intelligence
Figure 1: Annual Procurement Budgets: Global Pharmaceutical Industry Buyers in US$ (%), 2010-2012
Figure 2: Global Pharmaceutical Industry: Annual Procurement Budgets in US$ by Company (%), 2012
Figure 3: Global Pharmaceutical Industry: Annual Procurement Budgets in US$ by Region (%), 2012
Figure 4: Global Pharmaceutical Industry: Annual Procurement Budgets in US$ by Turnover (%), 2012
Figure 5: Change in Total Procurement Expenditure of Global Pharmaceutical Industry Buyers (%), 2010-2012
Figure 6: Global Pharmaceutical Industry: Expected Change in Total Procurement Expenditure by Company Type (%), 2012
Figure 7: Global Pharmaceutical Industry: Expected Change in Total Procurement Expenditure by Region (%), 2012
Figure 8: Global Pharmaceutical Industry: Expected Change in Total Procurement Expenditure by Company Turnover (%), 2012
Figure 9: Global Pharmaceutical Industry Manufacturers: Change in Expenditure by Products and Services (%), 2012
Figure 10: Global Pharmaceutical Industry CRO and CMO: Change in Expenditure by Products and Services (%), 2012
Figure 11: Global Pharmaceutical Industry: Increase in Expenditure on Products and Services by Region (%), 2012
Figure 12: Global Pharmaceutical Industry: Increase in Expenditure on Products and Services by Turnover (%), 2012
Figure 13: Global Pharmaceutical Industry: Variations in Regional Supplier Prices (%), 2012
Figure 14: Global Pharmaceutical Industry: Variations in Regional Supplier Prices by Company (%), 2012
Figure 15: Global Pharmaceutical Industry: Variations in Supplier Prices by Region (%), 2012
Figure 16: Global Pharmaceutical Industry: Variations in Regional Supplier Prices by Turnover (%), 2012
Figure 17: Global Pharmaceutical Industry: Critical Success Factors for Supplier Selection - Buyers vs. Suppliers, 2012
Figure 18: Global Pharmaceutical Industry: Critical Success Factors for Supplier Selection - Buyers vs. Suppliers, 2012
Figure 19: Critical Success Factors for Supplier Selection - All Global Pharmaceutical Industry Buyers, 2012
Figure 20: Global Pharmaceutical Industry: Future Procurement Objectives (%), 2012
Figure 21: Global Pharmaceutical Industry: Future Procurement Objectives by Company (%), 2012
Figure 22: Global Pharmaceutical Industry: Future Procurement Objectives by Region (%), 2012
Figure 23: Global Pharmaceutical Industry: Future Procurement Objectives by Turnover (%), 2012
Figure 24: E-Procurement in the Global Pharmaceutical Industry:(%), 2012
Figure 25: E-Procurement in the Global Pharmaceutical Industry: by Company (%), 2012
Figure 26: E-Procurement in the Global Pharmaceutical Industry by Region (%), 2012
Figure 27: E-Procurement in the Global Pharmaceutical Industry: by Turnover (%), 2012
1 Introduction
1.1 What is This Report About?
1.2 Definitions
1.3 Methodology
1.4 Profile of Survey Respondents: Global Pharmaceutical Industry
1.4.1 Profile of buyer respondents: global pharmaceutical industry
1.4.2 Profile of supplier respondents: global pharmaceutical industry
2 Executive Summary
3 Global Pharmaceutical Industry Buyer Spend Activity
3.1 Global Pharmaceutical Industry: Annual Procurement Budgets
3.1.1 Global pharmaceutical industry: annual procurement budgets by company type
3.1.2 Global pharmaceutical industry: annual procurement budgets by region
3.1.3 Global pharmaceutical industry: annual procurement budgets by company turnover
3.2 Global Pharmaceutical Industry: Planned Change in Procurement Spend
3.2.1 Global pharmaceutical industry: planned change in procurement spend by buyer type
3.2.2 Global pharmaceutical industry: planned change in procurement spend by region
3.2.3 Global pharmaceutical industry: planned change in procurement spend by company turnover
3.2.4 Global pharmaceutical industry: planned change in expenditure vs. revenue growth optimism
3.2.5 Global pharmaceutical industry: planned change in expenditure vs. cost containment
3.2.6 Global pharmaceutical industry: planned change in procurement spend - cross industry comparisons
3.3 Planned change in procurement spend by product and service category
3.3.1 Planned change in procurement spend by product and service category - region
3.3.2 Planned change in procurement spend by product and service category - company turnover
3.4 Global Pharmaceutical Industry: Variations in Regional Supplier Prices
3.4.1 Global pharmaceutical industry: variations in regional supplier prices by company type
3.4.2 Global pharmaceutical industry: variations in supplier prices by region
3.4.3 Global pharmaceutical industry: variations in regional supplier prices by company turnover
4 Global Pharmaceutical Industry:Procurement Behaviors and Strategies
4.1 Global Pharmaceutical Industry: Critical Success Factors for Supplier Selection
4.1.1 Global pharmaceutical industry: Critical success factors by company type
4.2 Future Procurement Objectives in the Global Pharmaceutical Industry
4.2.1 Future procurement objectives in the global pharmaceutical industry by company type
4.2.2 Future procurement objectives in the global pharmaceutical industry by region
4.2.3 Future procurement objectives in the global pharmaceutical industry by company turnover
4.3 E-procurement in the Global Pharmaceutical Industry
4.3.1 E-procurement in the global pharmaceutical industry by company type
4.3.2 E-procurement in the global pharmaceutical industry by region
4.3.3 E-procurement in the global pharmaceutical industry by company turnover
5 Appendix
5.1 Global Pharmaceutical Industry Survey Results - Closed Questions
5.2 Methodology
5.3 Contact us
5.4 About ICD Research
5.5 Disclaimer
Tabellenverzeichnis - Marktanalyse - Buyer Spend Activity and Procurement Behaviors and Strategies in the Pharmaceutical Industry - 2012-2013 : Survey Intelligence
Table 1: Total Global Pharmaceutical Industry Survey Respondents by Company Type, 2012
Table 2: Global Pharmaceutical Industry Buyer Respondents by Job Role (%), 2012
Table 3: Global Pharmaceutical Industry Buyer Respondents by Company Turnover (%), 2012
Table 4: Global Pharmaceutical Industry Buyer Respondents by Region (%), 2012
Table 5: Global Pharmaceutical Industry Supplier Respondents by Job Role (%), 2012
Table 6: Global Pharmaceutical Industry Supplier Respondents by Company Turnover (%), 2012
Table 7: Global Pharmaceutical Industry Supplier Respondents by Region (%), 2012
Table 8: Annual Procurement Budgets: Global Pharmaceutical Industry Buyers in US$ (%), 2010-2012
Table 9: Global Pharmaceutical Industry: Annual Procurement Budgets in US$ by Company (%), 2012
Table 10: Global Pharmaceutical Industry: Annual Procurement Budgets in US$ by Region (%), 2012
Table 11: Global Pharmaceutical Industry: Annual Procurement Budgets in US$ by Turnover (%), 2012
Table 12: Change in Total Procurement Expenditure of Global Pharmaceutical Industry Buyers (%), 2010-2012
Table 13: Global Pharmaceutical Industry: Change in Total Procurement Expenditure by Company Type (%), 2012
Table 14: Global Pharmaceutical Industry: Expected Change in Total Procurement Expenditure by Region (%), 2012
Table 15: Global Pharmaceutical Industry: Expected Change in Total Procurement Expenditure by Company Turnover (%), 2012
Table 16: Global Pharmaceutical Industry: Change in Expenditure vs. Revenue Growth (%), 2012
Table 17: Global Pharmaceutical Industry: Change in Expenditure vs. Cost Containment (%), 2012
Table 18: Planned Change in Procurement Spend: Cross Industry Comparison (%), 2012
Table 19: Global Pharmaceutical Industry Manufacturers: Change in Expenditure by Products and Services (%), 2012
Table 20: Global Pharmaceutical Industry CRO and CMO: Change in Expenditure by Products and Services (%), 2012
Table 21: Global Pharmaceutical Industry: Variations in Regional Supplier Prices (%), 2012
Table 22: Global Pharmaceutical Industry: Variations in Regional Supplier Prices by Company (%), 2012
Table 23: Global Pharmaceutical Industry: Variations in Supplier Prices by Region (%), 2012
Table 24: Global Pharmaceutical Industry: Variations in Regional Supplier Prices by Turnover (%), 2012
Table 25: Global Pharmaceutical Industry: Critical Success Factors for Supplier Selection - Buyers vs. Suppliers, 2012
Table 26: Critical Success Factors for Supplier Selection - All Global Pharmaceutical Industry Buyers, 2012
Table 27: Global Pharmaceutical Industry: Future Procurement Objectives (%), 2012
Table 28: Global Pharmaceutical Industry: Future Procurement Objectives by Company (%), 2012
Table 29: Global Pharmaceutical Industry: Future Procurement Objectives by Region (%), 2012
Table 30: Global Pharmaceutical Industry: Future Procurement Objectives by Turnover (%), 2012
Table 31: E-Procurement in the Global Pharmaceutical Industry(%), 2012
Table 32: E-Procurement in the Global Pharmaceutical Industry: by Company (%), 2012
Table 33: E-Procurement in the Global Pharmaceutical Industry by Region (%), 2012
Table 34: E-Procurement in the Global Pharmaceutical Industry by Turnover (%), 2012
Table 35: Survey Results - Closed Questions
Übersichtenverzeichnis - Marktanalyse - Buyer Spend Activity and Procurement Behaviors and Strategies in the Pharmaceutical Industry - 2012-2013 : Survey Intelligence
Figure 1: Annual Procurement Budgets: Global Pharmaceutical Industry Buyers in US$ (%), 2010-2012
Figure 2: Global Pharmaceutical Industry: Annual Procurement Budgets in US$ by Company (%), 2012
Figure 3: Global Pharmaceutical Industry: Annual Procurement Budgets in US$ by Region (%), 2012
Figure 4: Global Pharmaceutical Industry: Annual Procurement Budgets in US$ by Turnover (%), 2012
Figure 5: Change in Total Procurement Expenditure of Global Pharmaceutical Industry Buyers (%), 2010-2012
Figure 6: Global Pharmaceutical Industry: Expected Change in Total Procurement Expenditure by Company Type (%), 2012
Figure 7: Global Pharmaceutical Industry: Expected Change in Total Procurement Expenditure by Region (%), 2012
Figure 8: Global Pharmaceutical Industry: Expected Change in Total Procurement Expenditure by Company Turnover (%), 2012
Figure 9: Global Pharmaceutical Industry Manufacturers: Change in Expenditure by Products and Services (%), 2012
Figure 10: Global Pharmaceutical Industry CRO and CMO: Change in Expenditure by Products and Services (%), 2012
Figure 11: Global Pharmaceutical Industry: Increase in Expenditure on Products and Services by Region (%), 2012
Figure 12: Global Pharmaceutical Industry: Increase in Expenditure on Products and Services by Turnover (%), 2012
Figure 13: Global Pharmaceutical Industry: Variations in Regional Supplier Prices (%), 2012
Figure 14: Global Pharmaceutical Industry: Variations in Regional Supplier Prices by Company (%), 2012
Figure 15: Global Pharmaceutical Industry: Variations in Supplier Prices by Region (%), 2012
Figure 16: Global Pharmaceutical Industry: Variations in Regional Supplier Prices by Turnover (%), 2012
Figure 17: Global Pharmaceutical Industry: Critical Success Factors for Supplier Selection - Buyers vs. Suppliers, 2012
Figure 18: Global Pharmaceutical Industry: Critical Success Factors for Supplier Selection - Buyers vs. Suppliers, 2012
Figure 19: Critical Success Factors for Supplier Selection - All Global Pharmaceutical Industry Buyers, 2012
Figure 20: Global Pharmaceutical Industry: Future Procurement Objectives (%), 2012
Figure 21: Global Pharmaceutical Industry: Future Procurement Objectives by Company (%), 2012
Figure 22: Global Pharmaceutical Industry: Future Procurement Objectives by Region (%), 2012
Figure 23: Global Pharmaceutical Industry: Future Procurement Objectives by Turnover (%), 2012
Figure 24: E-Procurement in the Global Pharmaceutical Industry:(%), 2012
Figure 25: E-Procurement in the Global Pharmaceutical Industry: by Company (%), 2012
Figure 26: E-Procurement in the Global Pharmaceutical Industry by Region (%), 2012
Figure 27: E-Procurement in the Global Pharmaceutical Industry: by Turnover (%), 2012
- Global Vaccine Market
- Vaccine Market in Argentina
- Vaccine Market in Armenia
- Vaccine Market in Australia
- Vaccine Market in Austria
- Vaccine Market in Azerbaijan
- Vaccine Market in Bangladesh
- Vaccine Market in Belgium
- Vaccine Market in Bolivia
- Vaccine Market in Bulgaria
- Vaccine Market in Canada
- Vaccine Market in Chile
- Vaccine Market in China
- Vaccine Market in Colombia
- Vaccine Market in Czech Republic
- Vaccine Market in Denmark
- Vaccine Market in Ecuador
- Vaccine Market in Egypt
- Vaccine Market in Estonia
- Vaccine Market in Ethiopia
*Alle Preise sind netto ausgewiesen. In Abhängigkeit von Ihrer Rechnungsanschrift ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Unser Angebot richtet sich ausschließlich an Unternehmen, Gewerbetreibende und Freiberufler.
Für Sie protokollierte Studien / Marktanalysen:
zuletzt angesehene Studien:
Seite drucken
Seite empfehlen
Home | Werbung | Über marktforschung.de | AGB | Impressum | Sitemap | Suche © 2006 bis 2013 Alle Rechte bei marktforschung.de - Studie - Buyer Spend Activity and Procurement Behaviors and Strategies in the Pharmaceutical Industry - 2012-2013 : Survey Intelligence - Marktdaten / Marktanalysen bei marktforschung.de
